Market size, growth to 2033 and clinical trials, side by side.
The US is the bigger Iron Supplement market: $840 Mn against $161 Mn in 2023, about 5.2 times as large.
China grows faster: 8% a year, against 4.5%. The gap still grows from $679 Mn to $957 Mn by 2033.
Clinical research: 59 active trials in the US, 27 in China.
| Measure | ||
|---|---|---|
| Market size, 2023 | $840 Mn | $161 Mn |
| Market size, 2033 projected | $1.3 Bn | $347 Mn |
| Growth a year (CAGR) | 4.5% | 8% |
| Money added, 2023–2033 | $465 Mn | $186 Mn |
| Share of the world market | 42% | 8% |
| Size rank of 24 countries | #1 | #2 |
| Market per person, 2023 | $2.46 | $0.11 |
| Active clinical trials | 59 | 27 |
| Anaemia in women 15–49 % of women (WHO) | 15.0 2023 | 15.6 2023 |
| Full report | US report | China report |
US China · values between 2023 and 2033 are projected from the 2023 size and the CAGR.
The US is the bigger Iron Supplement market: $840 Mn against $161 Mn in 2023, about 5.2 times as large.
China grows faster: 8% a year, against 4.5%. The gap still grows from $679 Mn to $957 Mn by 2033.
Sources: market size and growth: Acuitas Health Analytics research (2023 base year, forecasts to 2033). Trials: ClinicalTrials.gov (fetched 10 Nov 2026); found by search words, so counts are a guide. Health figures: WHO. Population: World Bank.